List of Figures:
Figure 4-1: Molecular Diagnostics Market (Billion US$), 2008-2011
Figure 4-2: Genetic Testing Market (Billion US$), 2008-2011
Figure 4-3: Forecast for Molecular Diagnostics Market (Billion US$), 2012-2015
Figure 4-4: Forecast for Genetic Testing Market (Billion US$), 2012-2015
Figure 4-5: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)
Figure 4-6: Number of DTC Genetic Testing Companies by Country
Figure 6-1: Number of Laboratories and Diseases for Genetic Testing (1993-2010)
Figure 6-2: US - Share of Diagnostics Testing in Healthcare Spending
Figure 6-3: Europe - EQA Scheme Participation by Country (Number), 2010
Figure 8-1: Global - Next Generation Sequencing Market (Billion US$), 2011-2015
Figure 8-2: Global - NGS Application by Sector (%)
Figure 8-3: Global - Next Generation Sequencing Market by Player (%), 2010
Figure 10-1: Quest Diagnostics - Sales by Testing (%), 2010
Figure 10-2: Myriad Genetics - Sales by Products (%), 2011
List of Tables:
Table 4-1: Key Companies in DTC Genetic Testing Segment
Table 5-1: Test Availability and Market Size for Key Conditions
Table 6-1: US - FDA Approved Pharmacogenetic Tests
Table 6-2: EU - Key Indicators in Genetics Market
Table 6-3: Europe - Recognized Accreditation Bodies in Key Countries
Table 8-1: Listed Pharmacogenomic Biomarkers in FDA Approved Cancer Therapy Labels
Table 9-1: US - Key Elements for Genetic Testing Regulation
Table 9-2: EU - Genetic Testing Regulation in Key Countries